91,702 New COVID Cases, 3,403 Deaths in India; Tally Over 2.92 Cr
Catch all the updates on the coronavirus outbreak here.
India on Friday, 11 June, reported 91,702 new coronavirus cases, taking the tally in the country to 2,92,74,823. The death toll increased by 3,403 to 3,63,079.
According to the Union Health Ministry data, there are currently 11,21,671 active cases across the country, while 2,77,90,073 patients have been discharged so far, with 1,34,580 discharges reported in the last 24 hours.
- Maharashtra on Thursday reported 12,207 new coronavirus cases and 393 deaths, taking the tally in the state to 58,76,087 and the death toll to 1,03,748
Meanwhile, Delhi reported 305 new infections, with a positivity rate of 0.41 percent, and 44 fatalities on Thursday - The G7 will provide one billion doses to the world by the end of 2022 through sharing and financing schemes, Britain said on Thursday, news agency AFP reported
- The UK reportedly said it would donate at least 100 million vaccine doses within the next year
- More than 24.6 crore vaccine doses have been administered since India’s inoculation drive began in January
91,702 New COVID Cases, 3,403 Deaths in India; Tally Over 2.92 Crore
India on Friday reported 91,702 new coronavirus cases, taking the tally in the country to 2,92,74,823. The death toll increased by 3,403 to 3,63,079.
According to the Union Health Ministry data, there are currently 11,21,671 active cases across the country, while 2,77,90,073 patients have been discharged so far, with 1,34,580 discharges reported in the last 24 hours.
Covaxin Denied Emergency Use Approval by the US
Covaxin, India's indigenous vaccine made by Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology has been denied emergency use approval (EUA) in the United States.
The US Food and Drug Administration (FDA) sought more clinical trial data while rejecting the application.
Read the full story here.
'Preperation for National Serosurvey Done': Dr VK Paul
Dr VK Paul, Member-Health, Niti Aayog has, as per ANI, informed that preparation for national serosurvey has been done done and that the ICMR will begin work for next serosurvey this month.
However, Dr VK Paul also added: "But if we want to protect our geographies, we won't have depend on a national serosurvey alone, we'll have to encourage states for serosurveys too."
Dalit Poet Dr Siddalingah Dies of COVID Related Compliacations
Dalit poet Dr Siddalingah of Karnataka has passed away due to COVID-19 related complications. He is known for his autobiographical work Ooru Keri apart from his poems.
Curfew Extended in Some Districts of Manipur
Manipur Government extends curfew in districts of Imphal West, Imphal East, Bishnupur, Thoubal, Kakching, Churachandpur and Ukhrul, reported ANI. Limited activities are permitted, and the guidelines, including restrictions on inter-district movements, in respect of the remaining 9 districts will be applicable till 30 June.
Complete Lockdown in Kerala Over The Weekend, Only Essential Services Allowed: CM Vijayan
Kerala CM Pinarayi Vijayan has informed that the state will observe a complete lockdown on Saturday and Sunday and said that "people should cooperate". Only essential services will be allowed over the weekend.
Further, the CM, as per ANI, said: "The number of COVID cases is decreasing and also the rate of the spread of the infection. Lockdown implemented is showing results."
Corona Curfew From 5 am on 13 June to 5 am on 14 June in Chandigarh
The Chandigarh administration has informed that there shall be a Corona curfew from 5 am on 13 June till 5 am on 14 June in the Union Territory, according to ANI.
West Bengal Reports 4,883 New COVID Cases
West Bengal on Friday, 11 June, reported 4883 new COVID-19 cases, 4321 recoveries and 89 deaths in the last 24 hours.
Total cases 14,52,987
Total recoveries 14,21,064
Death toll 16,731
Active cases 15,192
(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)